N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide

C28H25FN4O6S2 — CID 71470375

IUPACN-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide
SMILESCS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1C(=O)[C@@H]3C4C5C6C7C5C(C7C64)[C@@H]3N(Cc3ccc(F)cc3)C1=O)N2
InChIInChI=1S/C28H25FN4O6S2/c1-40(36,37)31-12-6-7-13-14(8-12)41(38,39)32-27(30-13)24-26(34)23-21-17-15-16-19(17)22(20(16)18(15)21)25(23)33(28(24)35)9-10-2-4-11(29)5-3-10/h2-8,15-25,31H,9H2,1H3,(H,30,32)/t15?,16?,17?,18?,19?,20?,21?,22?,23-,24?,25+/m1/s1
InChIKeyZHGBGXWJJUAHLX-QRBRVVLJSA-N
MW596.66 g/mol
LogP1.92
Rot. Bonds5

About N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide

N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide (PubChem CID 71470375) has the molecular formula C28H25FN4O6S2 and a molecular weight of 596.66 g/mol. Its IUPAC name is N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide.

Molecular Properties

Compound NameN-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide
PubChem CID71470375
Molecular FormulaC28H25FN4O6S2
Molecular Weight596.66 g/mol
Exact Mass596.12
IUPAC NameN-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide
SMILESCS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1C(=O)[C@@H]3C4C5C6C7C5C(C7C64)[C@@H]3N(Cc3ccc(F)cc3)C1=O)N2
InChIInChI=1S/C28H25FN4O6S2/c1-40(36,37)31-12-6-7-13-14(8-12)41(38,39)32-27(30-13)24-26(34)23-21-17-15-16-19(17)22(20(16)18(15)21)25(23)33(28(24)35)9-10-2-4-11(29)5-3-10/h2-8,15-25,31H,9H2,1H3,(H,30,32)/t15?,16?,17?,18?,19?,20?,21?,22?,23-,24?,25+/m1/s1
InChIKeyZHGBGXWJJUAHLX-QRBRVVLJSA-N
XLogP1.92
TPSA142.08 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500596.66
LogP ≤ 51.92
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide?
The IUPAC name of N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide (CID 71470375) is N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide.
What is the SMILES notation for N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide?
The canonical SMILES for N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide is CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1C(=O)[C@@H]3C4C5C6C7C5C(C7C64)[C@@H]3N(Cc3ccc(F)cc3)C1=O)N2.
What is the InChIKey of N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide?
The InChIKey is ZHGBGXWJJUAHLX-QRBRVVLJSA-N. The full InChI is InChI=1S/C28H25FN4O6S2/c1-40(36,37)31-12-6-7-13-14(8-12)41(38,39)32-27(30-13)24-26(34)23-21-17-15-16-19(17)22(20(16)18(15)21)25(23)33(28(24)35)9-10-2-4-11(29)5-3-10/h2-8,15-25,31H,9H2,1H3,(H,30,32)/t15?,16?,17?,18?,19?,20?,21?,22?,23-,24?,25+/m1/s1.
What are the key properties of N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide?
N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide has a molecular weight of 596.66 g/mol, XLogP of 1.92, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[(1R,10S)-11-[(4-fluorophenyl)methyl]-12,14-dioxo-11-azahexacyclo[8.4.0.02,5.03,8.04,7.06,9]tetradecan-13-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]methanesulfonamide is sourced from PubChem (CID 71470375), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).